Join Professor Jay Bhattacharya and special guest Kim Witzak for an insightful conversation on patient advocacy and drug safety. Kim shares her deeply personal story, revealing how her husband's tragic experience with antidepressants propelled her into a mission for change. Together, they uncover the flaws in the FDA's drug approval process and the critical need for transparency and real-world safety measures.

Through Kim's experiences and insights, discover the power of collective action and the importance of amplifying patient voices for a healthier future.

Let us know your thoughts and ideas on these takes in the comment section below!

Receive Exclusive Episodes & Q&A Content by joining our Substack Community: https://www.illusionconsensus.com/

Sponsors
- Alcami Elements :https://www.alcamielements.com/
Receive 10% OFF first order or 30% OFF subscription order using code: ILLUSION

-Brownstone institute: https://brownstone.org/

Timestamps
00:00 Introduction & Kim's Background
14:06 Flaws in the FDA's Drug Approval Process
24:16 Balancing Patient Access and Safety Concerns
36:45 The Influence of Pharmaceutical Companies on the FDA
41:23 The Impact of Direct-to-Consumer Advertising
49:46 The Handling of COVID Vaccines: Lack of Debate and Pushback
58:14 The Power of Regular People: Speaking Up for Change